Ürolojik Sorunlar
Özet
Kanser hastalarında ürolojik komplikasyonlar, malignitelerin doğrudan etkileri, tedavi modalitelerinin yan etkileri ve hastalığın genel metabolik etkileri nedeniyle sık karşılaşılan ve yönetimi zorlayıcı klinik sorunlardır. Bu komplikasyonlar, hem hastaların yaşam kalitesini ciddi şekilde düşürebilmekte hem de kanser tedavisini sınırlayıcı faktörler haline gelebilmektedir. Özellikle obstrüktif nefropati, hematüri, hemorajik sistit, üriner inkontinans ve fistül gelişimi gibi durumlar, kanserin evresi, türü ve uygulanan tedaviye bağlı olarak sıklıkla gözlenmektedir. Obstrüktif nefropati, erken teşhis edilip tedavi edilmediği takdirde geri dönüşü olmayan böbrek hasarına yol açabilirken, hemorajik sistit ve hematüri gibi komplikasyonlar, hem hastaların semptom yönetiminde hem de tedavi protokollerinin sürdürülebilirliğinde ciddi zorluklar oluşturabilir. Üriner inkontinans ve üriner fistüller ise hastaların fiziksel rahatsızlıklarının yanı sıra sosyal izolasyon ve psikolojik stres gibi ek yükler doğurabilmektedir. Üroloji, onkoloji, radyasyon onkolojisi ve enfeksiyon hastalıkları uzmanlarının ortak çalışması, hem hastaların yaşam kalitesini iyileştirmekte hem de tedavi başarı oranlarını artırmaktadır. Multidisipliner iş birliği ve hasta merkezli yaklaşımlar, kanser hastalarında ürolojik komplikasyonların yönetiminde kritik bir rol oynamaktadır.
Urological complications in cancer patients are common and challenging clinical problems due to the direct effects of malignancies, side effects of treatment modalities and general metabolic effects of the disease. These complications can both seriously reduce the quality of life of patients and become limiting factors in cancer treatment. In particular, obstructive nephropathy, haematuria, haemorrhagic cystitis, urinary incontinence and fistula development are frequently observed depending on the stage, type and treatment of cancer. Obstructive nephropathy can lead to irreversible kidney damage if not diagnosed and treated early, while complications such as haemorrhagic cystitis and haematuria can pose serious challenges in both symptom management and sustainability of treatment protocols. Urinary incontinence and urinary fistulae may cause additional burdens such as social isolation and psychological stress in addition to the physical discomfort of the patients. Collaboration between urology, oncology, radiation oncology and infectious diseases specialists improves the quality of life of patients and increases treatment success rates. In this context, multidisciplinary collaboration and patient-centred approaches play a critical role in the management of urological complications in cancer patients.
Referanslar
Artiles Medina A, Laso García I, González Tello F, Álvarez Rodríguez S, Hevia Palacios M, Mata Alcaraz M, et al. The challenging management of malignant ureteral obstruction: Analysis of a series of 188 cases. Curr Urol. 2024 Mar;18(1):34–42.
Pérez-Aizpurua X, Cabello Benavente R, Bueno Serrano G, Alcázar Peral JM, Gómez-Jordana Mañas B, Tufet I Jaumot J, et al. Obstructive uropathy: Overview of the pathogenesis, etiology and management of a prevalent cause of acute kidney injury. World J Nephrol. 2024 Jun 25;13(2):93322.
Krajewski W, Kamińska D, Poterek A, Małkiewicz B, Kłak J, Zdrojowy R, et al. Pathogenicity of BK virus on the urinary system. Cent European J Urol. 2020 Feb 27;73(1):94–103.
Mourmouris. Obstructive uropathy: from etiopathology to therapy. World J Nephrol Urol. 2014;
Feliciangeli V, Noce A, Montalto G, Germani S, Miano R, Asimakopoulos AD. Non-dilated obstructive nephropathy. Clin Kidney J. 2024 Oct;17(10):sfae249.
Sen KK, Mohan C, Verma BS. Magnetic resonance urography in obstructive uropathy. Med J Armed Forces India. 2008 Apr;64(2):145–7.
Ahmed Moawad M, El-Zawawy M. The role of multidetector computed tomography urography in the evaluation of obstructive uropathy. Menoufia Med J. 2015;28(2):554.
Farrell MB, Banks KP, Peacock JG. Diuretic Renal Scintigraphy. J Nucl Med Technol. 2022 Dec;50(4):319–21.
Zhu GG, Rais-Bahrami S. Diagnosis and management of obstructive uropathy in the setting of advanced pelvic malignancies. J Nephrol Res. 2015 Dec 29;1(3):90–6.
Blackmur J, Scottish Malignant Ureteric Obstruction Study Group. Management of malignant ureteric obstruction with ureteric stenting or percutaneous nephrostomy. Br J Surg. 2024 Jan 31;111(2).
Wong L-M, Cleeve LK, Milner AD, Pitman AG. Malignant ureteral obstruction: outcomes after intervention. Have things changed? J Urol. 2007 Jul;178(1):178–83; discussion 183.
Savva-Bordalo J, Pinho Vaz C, Sousa M, Branca R, Campilho F, Resende R, et al. Clinical effectiveness of hyperbaric oxygen therapy for BK-virus-associated hemorrhagic cystitis after allogeneic bone marrow transplantation. Bone Marrow Transplant. 2012 Aug;47(8):1095–8.
Jimbo M. Evaluation and management of hematuria. Prim Care. 2010 Sep;37(3):461–72, vii.
Grossfeld GD, Litwin MS, Wolf JS, Hricak H, Shuler CL, Agerter DC, et al. Evaluation of asymptomatic microscopic hematuria in adults: the American Urological Association best practice policy--part I: definition, detection, prevalence, and etiology. Urology. 2001 Apr;57(4):599–603.
Schmitz-Dräger BJ, Kuckuck EC, Zuiverloon TCM, Zwarthoff EC, Saltzman A, Srivastava A, et al. Microhematuria assessment an IBCN consensus-Based upon a critical review of current guidelines. Urol Oncol. 2016 Oct;34(10):437–51.
Avidor Y, Nadu A, Matzkin H. Clinical significance of gross hematuria and its evaluation in patients receiving anticoagulant and aspirin treatment. Urology. 2000 Jan;55(1):22–4.
Yao Q, Wu M, Zhou J, Zhou M, Chen D, Fu L, et al. Treatment of Persistent Gross Hematuria with Tranexamic Acid in Autosomal Dominant Polycystic Kidney Disease. Kidney Blood Press Res. 2017 Apr 11;42(1):156–64.
Choi H, Kim DW, Jung E, Kye YC, Lee J, Jo S, et al. Impact of intravesical administration of tranexamic acid on gross hematuria in the emergency department: A before-and-after study. Am J Emerg Med. 2023 Jun;68:68–72.
Sekito T, Sadahira T, Watanabe T, Maruyama Y, Watanabe T, Iwata T, et al. Medical uses for silver nitrate in the urinary tract (Review). Wrld Acd Sci. 2022 Jan 21;4(1):6.
Mugiya S, Ozono S, Nagata M, Takayama T, Furuse H, Ushiyama T. Ureteroscopic evaluation and laser treatment of chronic unilateral hematuria. J Urol. 2007 Aug;178(2):517–20.
Korkmaz A, Topal T, Oter S. Pathophysiological aspects of cyclophosphamide and ifosfamide induced hemorrhagic cystitis; implication of reactive oxygen and nitrogen species as well as PARP activation. Cell Biol Toxicol. 2007 Sep;23(5):303–12.
Li KD, Jones CP, Hakam N, Erickson BA, Vanni AJ, Chancellor MB, et al. Haemorrhagic cystitis: a review of management strategies and emerging treatments. BJU Int. 2023 Dec;132(6):631–7.
Williams JA, Clarke D, Dennis WA, Dennis EJ, Smith ST. The treatment of pelvic soft tissue radiation necrosis with hyperbaric oxygen. Am J Obstet Gynecol. 1992 Aug;167(2):412–5; discussion 415.
Russo P. Urologic emergencies in the cancer patient. Semin Oncol. 2000 Jun;27(3):284–98.
Johnston D, Schurtz E, Tourville E, Jones T, Boemer A, Giel D. Risk Factors Associated with Severity and Outcomes in Pediatric Patients with Hemorrhagic Cystitis. J Urol. 2016 Apr;195(4 Pt 2):1312–7.
Montgomery BD, Boorjian SA, Ziegelmann MJ, Joyce DD, Linder BJ. Intravesical silver nitrate for refractory hemorrhagic cystitis. Turk J Urol. 2016 Sep;42(3):197–201.
Westerman ME, Boorjian SA, Linder BJ. Safety and efficacy of intravesical alum for intractable hemorrhagic cystitis: A contemporary evaluation. Int Braz J Urol. 2016;42(6):1144–9.
Yang T-K, Wang Y-J, Li H-J, Yu Y-F, Huang K-W, Cheng JC-H. Efficacy and Safety of Hyperbaric Oxygen Therapy for Radiation-Induced Hemorrhagic Cystitis: A Systematic Review and Meta-Analysis. J Clin Med. 2024 Aug 12;13(16).
Hensley ML, Hagerty KL, Kewalramani T, Green DM, Meropol NJ, Wasserman TH, et al. American Society of Clinical Oncology 2008 clinical practice guideline update: use of chemotherapy and radiation therapy protectants. J Clin Oncol. 2009 Jan 1;27(1):127–45.
Hensley ML, Schuchter LM, Lindley C, Meropol NJ, Cohen GI, Broder G, et al. American Society of Clinical Oncology clinical practice guidelines for the use of chemotherapy and radiotherapy protectants. J Clin Oncol. 1999 Oct;17(10):3333–55.
Vose JM, Reed EC, Pippert GC, Anderson JR, Bierman PJ, Kessinger A, et al. Mesna compared with continuous bladder irrigation as uroprotection during high-dose chemotherapy and transplantation: a randomized trial. J Clin Oncol. 1993 Jul;11(7):1306–10.
Athanassiou H, Antonadou D, Coliarakis N, Kouveli A, Synodinou M, Paraskevaidis M, et al. Protective effect of amifostine during fractionated radiotherapy in patients with pelvic carcinomas: results of a randomized trial. Int J Radiat Oncol Biol Phys. 2003 Jul 15;56(4):1154–60.
Gacci M, De Nunzio C, Sakalis V, Rieken M, Cornu J-N, Gravas S. Latest Evidence on Post-Prostatectomy Urinary Incontinence. J Clin Med. 2023 Feb 2;12(3).
Daugherty M, Chelluri R, Bratslavsky G, Byler T. Are we underestimating the rates of incontinence after prostate cancer treatment? Results from NHANES. Int Urol Nephrol. 2017 Oct;49(10):1715–21.
Nakayama N, Tsuji T, Aoyama M, Fujino T, Liu M. Quality of life and the prevalence of urinary incontinence after surgical treatment for gynecologic cancer: a questionnaire survey. BMC Womens Health. 2020 Jul 17;20(1):148.
Ruby CM, Hanlon JT, Boudreau RM, Newman AB, Simonsick EM, Shorr RI, et al. The effect of medication use on urinary incontinence in community-dwelling elderly women. J Am Geriatr Soc. 2010 Sep;58(9):1715–20.
Gormley EA, Lightner DJ, Burgio KL, Chai TC, Clemens JQ, Culkin DJ, et al. Diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA/SUFU guideline. J Urol. 2012 Dec;188(6 Suppl):2455–63.
Gormley EA, Lightner DJ, Faraday M, Vasavada SP, American Urological Association, Society of Urodynamics, Female Pelvic Medicine. Diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA/SUFU guideline amendment. J Urol. 2015 May;193(5):1572–80.
Nygaard I. Clinical practice. Idiopathic urgency urinary incontinence. N Engl J Med. 2010 Sep 16;363(12):1156–62.
Brown JS, Bradley CS, Subak LL, Richter HE, Kraus SR, Brubaker L, et al. The sensitivity and specificity of a simple test to distinguish between urge and stress urinary incontinence. Ann Intern Med. 2006 May 16;144(10):715–23.
Hay-Smith EJC, Herderschee R, Dumoulin C, Herbison GP. Comparisons of approaches to pelvic floor muscle training for urinary incontinence in women. Cochrane Database Syst Rev. 2011 Dec 7;(12):CD009508.
Brown HW, Braun EJ, Wise ME, Myers S, Li Z, Sampene E, et al. Small-Group, Community-Member Intervention for Urinary and Bowel Incontinence: A Randomized Controlled Trial. Obstet Gynecol. 2019 Sep;134(3):600–10.
Filocamo MT, Li Marzi V, Del Popolo G, Cecconi F, Villari D, Marzocco M, et al. Pharmacologic treatment in postprostatectomy stress urinary incontinence. Eur Urol. 2007 Jun;51(6):1559–64.
Suarez OA, McCammon KA. The artificial urinary sphincter in the management of incontinence. Urology. 2016 Jun;92:14–9.
Bodner-Adler B, Hanzal E, Pablik E, Koelbl H, Bodner K. Management of vesicovaginal fistulas (VVFs) in women following benign gynaecologic surgery: A systematic review and meta-analysis. PLoS ONE. 2017 Feb 22;12(2):e0171554.
Shrestha DB, Budhathoki P, Karki P, Jha P, Mainali G, Dangal G, et al. Vesico-Vaginal Fistula in Females in 2010-2020: a Systemic Review and Meta-analysis. Reprod Sci. 2022 Dec;29(12):3346–64.
Blaivas JG, Heritz DM, Romanzi LJ. Early versus late repair of vesicovaginal fistulas: vaginal and abdominal approaches. J Urol. 1995 Apr;153(4):1110–2; discussion 1112.
Selzman AA, Spirnak JP, Kursh ED. The changing management of ureterovaginal fistulas. J Urol. 1995 Mar;153(3 Pt 1):626–8.
Al-Otaibi KM. Ureterovaginal fistulas: The role of endoscopy and a percutaneous approach. Urol Ann. 2012 May;4(2):102–5.
Morse FP, Dretler SP. Diagnosis and treatment of colovesical fistula. J Urol. 1974 Jan;111(1):22–4.
Najjar SF, Jamal MK, Savas JF, Miller TA. The spectrum of colovesical fistula and diagnostic paradigm. Am J Surg. 2004 Nov;188(5):617–21.
Singh V, Mandhani PA, Mehrotra S, Sinha RJ. Laparoscopic repair of vesicouterine fistula: a brief report with review of literature. Urol J. 2011;8(2):149–52.
Fox JA, Krambeck A, McPhail EF, Lightner D. Ureteroarterial fistula treatment with open surgery versus endovascular management: long-term outcomes. J Urol. 2011 Mar;185(3):945–50.
